Based on the above findings, sEVs containing miR-27a-3p could promote M2 polarization of macrophage and proliferation of hepatoma cells by targeting SPRY2, leading to the progression of hepatocellular carcinoma (Figure 7). The gene discussed is SPRY2; the disease is hepatocellular carcinoma.